CORC

在结果中检索

CORC

浏览/检索结果: 共14条，第1-10条 帮助

限定条件                    
已选(0)清除 条数/页：   排序方式：
Superior Salvage Treatment with Regimen Containing Sorafenib for Relapse of Acute Myeloid Leukemia with FLT3-ITD after Allo-HSCT 会议论文
BLOOD, 2018-11-29
作者:  Xuan, Li;  Wang, Yu;  Chen, Jia;  Jiang, Erlie;  Gao, Li
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
First-line axitinib versus sorafenib in Asian patients with metastatic renal cell carcinoma (mRCC): Subgroup analysis of data from a phase III trial 会议论文
ANNALS OF ONCOLOGY, 2017-11-01
作者:  Sheng, X.;  Bi, F.;  Ren, X.;  Cheng, Y.;  Wang, J.
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04
Concurrent sorafenib therapy extends the interval to subsequent TACE for patients with unresectable hepatocellular carcinoma 会议论文
ANNALS OF ONCOLOGY, 2015-12-01
作者:  Yao, X.;  Yan, D.;  Zeng, H.;  Liu, D.;  Li, H.
收藏  |  浏览/下载：1/0  |  提交时间：2020/01/04
STORM: A phase III randomized, double-blind, placebo-controlled trial of adjuvant sorafenib after resection or ablation to prevent recurrence of hepatocellular carcinoma (HCC) 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2014-05-20
作者:  Bruix, Jordi;  Takayama, Tadatoshi;  Mazzaferro, Vincenzo;  Chau, Gar-Yang;  Yang, Jiamei
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/13
A multicenter, noncontrolled clinical study of sorafenib adjuvant therapy in advanced renal cell carcinoma 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2014-05-20
作者:  Ye, Dingwei;  He, Zhisong;  Sun, Yinghao;  Kong, Chuize;  Xie, Liping
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/13
Safety and tolerability of sorafenib for treatment of locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer (RAI-rDTC): Detailed analyses from the phase III DECISION trial. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2014-05-20
作者:  Worden, Francis P.;  Fassnacht, Martin;  Shi, Yuankai;  Hadjieva, Tatiana;  Bonichon, Francoise
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13
Population PK modeling and exposure-response analyses of sorafenib in patients with radioactive iodine-refractory differentiated thyroid cancer (RAI-rDTC) in the phase III DECISION trial. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2014-05-20
作者:  Bastholt, Lars;  Brose, Marcia S.;  Jarzab, Barbara;  Schlumberger, Martin;  Siena, Salvatore
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/13
含吡啶-2-酰肼结构化合物的抗肿瘤活性研究 会议论文
中国化学会第八届有机化学学术会议暨首届重庆有机化学国际研讨会, 重庆, 2013-10-17
作者:  张莉婧;  陈晓光;  冯志强;  秦爱方;  王克
收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13
Axitinib versus sorafenib as second-line therapy in Asian patients with metastatic renal cell carcinoma (mRCC): Results from a registrational study. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2012-05-20
作者:  Qin, Shukui;  Bi, Feng;  Cheng, Ying;  Guo, Jun;  Ren, Xiu Bao
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13
PATIENT CHARACTERISTICS IN RENAL CELL CARCINOMA AND DAILY PRACTICE TREATMENT WITH SORAFENIB (PREDICT) IN CHINA 会议论文
ANNALS OF ONCOLOGY, 2012-09-01
作者:  Ye, D-W.;  Guo, J.;  Zhou, A.;  Huang, Y.;  Li, H.
收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13

©版权所有 ©2017 CSpace - Powered by CSpace